VIDEO: SATIVEX JUST APPROVED IN 22ND COUNTRY! Sativex Cannabinoid spray is for the treatment of spasticity due to Multiple Sclerosis

If you think medical marijuana cards are crazy, prepare to go nuts:

GW Pharmaceuticals' cannabis-derived drug Sativex has been recommended for approval in France.
The pharmaceutical company has created the first prescription drug spray from marijuana plants. The drug which is sprayed under the tongue has already been approved in 22 countries including Britain, Spain, Germany, Canada, Denmark, Norway, Israel, Austria, Poland, Sweden, Italy and Finland..

Sativex was developed to treat multiple sclerosis patients with symptoms including neuropathic pain, spasticity and overactive bladder, but also has the potential to treat pain caused by cancer.

Sativex was developed to treat multiple sclerosis patients with symptoms including neuropathic pain, spasticity and overactive bladder, but also has the potential to treat pain caused by cancer

 SATIVEX GROW-FACTORY

Story Source: The above story is based on materials provided by NEWS DISTRIBUTION NETWORK, INC.

Note: Materials may be edited for content and length

Click here to see